(Q30451184)

English

Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers (English)

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

0 references

Frederick G Hayden

1

object named as

Frederick G Hayden

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

5

object named as

Merril Gersten

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

author name string

Ronald B Turner

2

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Jack M Gwaltney

3

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Kathy Chi-Burris

4

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Poe Hsyu

6

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Amy K Patick

7

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

George J Smith

8

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Leora S Zalman

9

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

47

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

12

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

3907-3916

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Combined antiviral-antimediator treatment for the common cold

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Exacerbations: etiology and pathophysiologic mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Protease inhibitors as antiviral agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Viruses and Bacteria in the Etiology of the Common Cold

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Frequency and natural history of rhinovirus infections in adults during autumn

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Intranasal pirodavir (R77,975) treatment of rhinovirus colds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

20 June 2018

Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296196

26 November 2018

Interruption of Experimental Rhinovirus Transmission

1 reference

https://pubmed.ncbi.nlm.nih.gov/14638501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds

1 reference

https://pubmed.ncbi.nlm.nih.gov/14638501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds

1 reference

https://pubmed.ncbi.nlm.nih.gov/14638501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.47.12.3907-3916.2003

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30451184&oldid=2050015459"